Literature DB >> 30883354

Cyclooxygenase-2 is Essential for Mediating the Effects of Calcium Ions on Stimulating Phosphorylation of Tau at the Sites of Ser 396 and Ser 404.

Long-Long Cao1, Pei-Pei Guan1, Yun-Yue Liang1, Xue-Shi Huang1, Pu Wang1.   

Abstract

Alzheimer's disease (AD) is reported to be associated with the accumulation of calcium ions (Ca2+), which is responsible for the phosphorylation of tau. Although a series of evidence have demonstrated this phenomenon, the inherent mechanisms remain unknown. Using tauP301S and cyclooxygenase-2 (COX-2) transgenic mice and neuroblastoma (n)2a cells as in vivo and in vitro experimental models, we found that Ca2+ stimulates the phosphorylation of tau by activating COX-2 in a prostaglandin (PG) E2-dependent EP receptor-activating manner. Specifically, Ca2+ incubation stimulated COX-2 and PGE2 synthase activity, microsomal PGE synthase 1 and the synthesis of PGE2 by activating the transcriptional activity of nuclear factor kappa-light-chain-enhancer of activated B cells (NF-κB) in n2a cells. Elevated levels of PGE2 were responsible for phosphorylating tau in an EP-1, -2, and -3 but not EP4-dependent glycogen synthase kinase 3-activating manner. These observations were corroborated by results that showed tau was phosphorylated when it colocalized with activated COX-2 in tauP301S and COX-2 transgenic mice or n2a cells. To further validate these observations, treatment of mice with the COX-2 inhibitor rofecoxib decreased the phosphorylation of tau via EP1-3 but not EP4. Collectively, our observations fill the gaps between Ca2+ and the phosphorylation of tau in a COX-2-dependent mechanism, which potentially provides therapeutic targets for combating AD.

Entities:  

Keywords:  Alzheimer’s disease; EP receptors; cyclooxygenase-2; prostaglandin zzm321990E2; tau

Year:  2019        PMID: 30883354     DOI: 10.3233/JAD-181066

Source DB:  PubMed          Journal:  J Alzheimers Dis        ISSN: 1387-2877            Impact factor:   4.472


  6 in total

1.  Cyclooxygenase-2 is critical for the propagation of β-amyloid protein and reducing the glycosylation of tau in Alzheimer's disease.

Authors:  Pei-Pei Guan; Xin Yu; Yan-Hui Zou; Pu Wang
Journal:  Cell Mol Immunol       Date:  2019-09-24       Impact factor: 11.530

Review 2.  The Role of Eicosanoids in Alzheimer's Disease.

Authors:  Roger G Biringer
Journal:  Int J Environ Res Public Health       Date:  2019-07-18       Impact factor: 3.390

3.  Downregulating expression of OPTN elevates neuroinflammation via AIM2 inflammasome- and RIPK1-activating mechanisms in APP/PS1 transgenic mice.

Authors:  Long-Long Cao; Pei-Pei Guan; Shen-Qing Zhang; Yi Yang; Xue-Shi Huang; Pu Wang
Journal:  J Neuroinflammation       Date:  2021-12-03       Impact factor: 8.322

Review 4.  Elevating the Levels of Calcium Ions Exacerbate Alzheimer's Disease via Inducing the Production and Aggregation of β-Amyloid Protein and Phosphorylated Tau.

Authors:  Pei-Pei Guan; Long-Long Cao; Pu Wang
Journal:  Int J Mol Sci       Date:  2021-05-31       Impact factor: 5.923

5.  The Regulating Mechanism of Chrysophanol on Protein Level of CaM-CaMKIV to Protect PC12 Cells Against Aβ25-35-Induced Damage.

Authors:  Ting Ye; Hua-Wu Gao; Wei-Ting Xuan; Shu Ye; Peng Zhou; Xin-Quan Li; Yan Wang; Hang Song; Yan-Yan Liu; Biao Cai
Journal:  Drug Des Devel Ther       Date:  2020-07-13       Impact factor: 4.162

6.  Phosphorylation of Tau and α-Synuclein Induced Neurodegeneration in MPTP Mouse Model of Parkinson's Disease.

Authors:  Shanshan Hu; Meigui Hu; Jian Liu; Bei Zhang; Zhen Zhang; Fiona H Zhou; Liping Wang; Jianghui Dong
Journal:  Neuropsychiatr Dis Treat       Date:  2020-03-04       Impact factor: 2.570

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.